...
首页> 外文期刊>Biochemistry >Comparison of two independent crystal structures of human dihydrofolate reductase ternary complexes reduced with nicotinamide adenine dinucleotide phosphate and the very tight-binding inhibitor PT523
【24h】

Comparison of two independent crystal structures of human dihydrofolate reductase ternary complexes reduced with nicotinamide adenine dinucleotide phosphate and the very tight-binding inhibitor PT523

机译:烟酰胺腺嘌呤二核苷酸磷酸和非常紧密结合的抑制剂PT523还原的人二氢叶酸还原酶三元复合物的两个独立晶体结构的比较

获取原文
获取原文并翻译 | 示例

摘要

Structural data for two independent crystal forms (monoclinic, C2, and orthorhombic, P2(1)2(1)2(1)) of the ternary complex of the potent antitumor agent PT523 [N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine], reduced nicotinamide adenine dinucleotide phosphate (NADPH), and recombinant human dihydrofolate reductase (hDHFR) reveals multiple binding orientations for the hemiphthaloyl group of the inhibitor. Analysis of these data shows that PT523 binds with its pteridine ring in the same orientation observed for methotrexate (MTX) analogues. However, in each structure, the hemiphthaloyl ring occupies three alternate conformations. In the C2 lattice, the phthaloyl moiety binds in two extended conformations, A and C, with each conformer having a 180 degrees flip of the o-carboxylate group, and a third, lower occupancy conformer B, with the phthaloyl group folded within contact of the active-site pocket. In the orthorhombic lattice, PT523 also has three conformers for the phthaloyl group; however, these differ from those observed in the monoclinic lattice. Two major conformers, A and C, are displaced on either side of the extended position observed in the C2 lattice, one near the folded B conformer of the C2 lattice and the other extended. These conformers form tighter intermolecular contacts than those in the C2 lattice. Conformer B is folded back away from the active site in a unique position. There are also significant differences in the conformation of the adenine-ribose moiety of NADPH in both complexes that differ from that observed for other inhibitor-NADPH-hDHFR ternary complexes. These data suggest that the added intermolecular contacts made by the hemiphaloyl group of PT523 contribute to its tighter binding to hDHFR than MTX, which does not extend as far from the active site and cannot make these contacts. These crystallographic observations of multiple conformations for the hemiphthaloyl group are in general agreement with solution NMR data for the binding of PT523 to hDHFR [Johnson et al. (1997) Biochemistry 36, 4399-4411], which show that the hemiphthaloyl group may adopt more than one conformation. However, the crystallographic data reveal more discretely occupied positions than can be interpreted from the solution data. These results suggest that crystal packing interactions may influence their stability.
机译:强效抗肿瘤药PT523 [N alpha-(4-amino-4-deoxypteroyl)的三元复合物的两个独立晶体形式(单斜晶C2和斜方晶P2(1)2(1)2(1))的结构数据)-Nδ-半邻苯二甲酰基-L-鸟氨酸],还原的烟酰胺腺嘌呤二核苷酸磷酸(NADPH)和重组人二氢叶酸还原酶(hDHFR)显示抑制剂的半邻苯二甲酰基具有多个结合方向。对这些数据的分析表明,PT523的蝶啶环以与甲氨蝶呤(MTX)类似物相同的方向结合。然而,在每个结构中,半邻苯二甲酰基环占据三个交替的构象。在C2晶格中,邻苯二甲酰基部分以两个扩展的构象A和C结合,每个构象异构体的邻羧酸酯基团翻转180度,而第三个低占据构象异构​​体B的邻苯二甲酸酯基团折叠成与活动现场的口袋。在斜方晶格中,PT523还具有三个邻苯二甲酰基构象。然而,这些不同于在单斜晶格中观察到的那些。在C2晶格中观察到的两个主要构象异构体A和C在延伸位置的任一侧均发生位移,一个靠近C2晶格的折叠B构象异构体,另一个延伸。这些构象异构体形成的分子间接触比C2晶格紧密。合格者B在独特位置被折叠远离活动部位。在两种复合物中,NADPH的腺嘌呤-核糖部分的构象也存在显着差异,这与其他抑制剂-NADPH-hDHFR三元复合物所观察到的不同。这些数据表明,由PT523的半环酰基形成的分子间接触增加了其与hDHFR的结合,而与MTX的结合更紧密,MTX的延伸距离活性位点不远,也无法形成这些接触。这些对半邻苯二甲酰基多个构象的晶体学观察结果与溶液NMR数据有关,即PT523与hDHFR的结合[Johnson et al。 (1997)Biochemistry 36,4399-4411],其表明半邻苯二甲酰基可采用不止一种构象。但是,晶体学数据揭示了比溶液数据可解释的更多的离散占据位置。这些结果表明晶体堆积相互作用可能影响其稳定性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号